Hepatitis C virus infection in systemic lupus erythematosus: A case-control study

Journal of Rheumatology

Volumn 30, Issue 7, 2003, Pages 1473-1478

  Perlemuter, Gabriel ^b   Cacoub, Patrice ^a   Sbaï, Abdallah ^b   Hausfater, Pierre ^b   Thibault, Vincent ^b   Huong, Du Le Thi ^a   Wechsler, Bertrand ^a   Buffet, Catherine ^b   Piette, Jean Charles ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b NONE

Author keywords

Antinuclear antibodies; Autoantibodies; Cryoglobulin; Extrahepatic manifestations; Hepatitis C virus; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CRYOGLOBULIN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHRONIC ACTIVE HEPATITIS; CLINICAL ARTICLE; COMORBIDITY; CONNECTIVE TISSUE DISEASE; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, VIRAL; ANTIRHEUMATIC AGENTS; BIOPSY; CRYOGLOBULINS; FEMALE; FRANCE; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RNA, VIRAL;

EID: 0037829147     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Johnson AE, Gordon C, Hobbs FD, Bacon PA. Undiagnosed systemic lupus erythematosus in the community. Lancet 1996;347:367-9.
2. Gourley IS, Patterson CC, Bell AL. The prevalence of systemic lupus erythematosus in Northern Ireland. Lupus 1997;6:399-403.
3. Theofilopoulos AN. Role of the thymus in murine lupus and cellular transfer of the disease. Arthritis Rheum 1982;25:726-33.
4. Cacoub P, Renou C, Rosenthal E, et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hépatite C. Medicine Baltimore 2000;79:47-56.
5. Tan EM, Fritzler MJ, McDougal JS, et al. Reference sera for antinuclear antibodies. I. Antibodies to native DNA, Sm, nuclear RNP, and SS-B/La. Arthritis Rheum 1982;25:1003-5.
6. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997;349:825-32.
7. Bonacini M, Puoti M. Hepatitis C in patients with human immunodeficiency virus infection: diagnosis, natural history, meta-analysis of sexual and vertical transmission, and therapeutic issues. Arch Intern Med 2000;160:3365-73.
8. Haddad J, Deny P, Munz-Gotheil C, et al. Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992;339:321-3.
9. Ramos-Casals M, Garcia-Carrasco M, Cervera R, et al. Hepatitis C virus infection mimicking primary Sjogren syndrome. A clinical and immunologic description of 35 cases. Medicine Baltimore 2001;80:1-8.
10. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327:1490-5.
11. Cacoub P, Poynard T, Ghillani P, et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum 1999;42:2204-12.
12. Ramos-Casals M, Font J, Garcia-Carrasco M, et al. Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus. Arthritis Rheum 2000;43:2801-6.
13. Marchesoni A, Battafarano N, Podico M, Tosi S. Hepatitis C virus antibodies and systemic lupus erythematosus [letter]. Clin Exp Rheumatol 1995;13:267.
14. Kowdley KV, Subler DE, Scheffel J, Moore B, Smith H. Hepatitis C virus antibodies in systemic lupus erythematosus. J Clin Gastroenterol 1997;25:437-9.
15. Cacoub P, Musset L, Amoura Z, et al. Anticardiolipin, anti-beta2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobutinemia. Multivirc Group. J Rheumatol 1997;24:2139-44.
16. Musset L, Diemert MC, Taibi F, et al. Characterization of cryoglobulins by immunoblotting. Clin Chem 1992;38:798-802.
17. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974;57:775-88.
18. Cacoub P, Musset L, Hausfater P, et al. No evidence for abnormal immune activation in peripheral blood T cells in patients with hepatitis C virus (HCV) infection with or without cryoglobulinaemia. Multivirc Group. Clin Exp Immunol 1998:113:48-54.
19. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994;20:15-20.
20. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
21. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
22. Roti E, Minelli R, Giuberti T, et al. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha. Am J Med 1996;101:482-7.
23. Zignego AL, Macchia D, Monti M, et al. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 1992;15:382-6.
24. Cacoub P, Lunel-Fabiani F, Du LT. Polyarteritis nodosa and hepatitis C virus infection. Ann Intern Med 1992;116:605-6.
25. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II mixed cryoglobulinemia. N Engl J Med 1992;31:369-76.
26. Casato M, Agnello V, Pucillo LP, et al. Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus. Blood 1997;90:3865-73.
27. McMurray RW, Elboume K. Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 1997;26:689-701.
28. Pawlotsky JM, Roudot-Thoraval F, Simmonds P, et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995;122:169-73.
29. Manns MP, Rambusch EG. Autoimmunity and extrahepatic manifestations in hepatitis C virus infection. J Hepatol 1999;31 Suppl 1:39-42.
30. Chang DM, Su WL, Chu SJ. The expression and significance of intracellular T helper cytokines in systemic lupus erythematosus. Immunol Invest 2002;31:1-12.
31. Gonzalez-Peralta RP, Davis GL, Lau JY. Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection. J Hepatol 1994;21:255-9.
32. Boyer N, Marcellin P. Pathogenesis, diagnosis and management of hepatitis C. J Hepatol 2000;32:98-112.
33. Runyon BA, LaBrecque DR, Anuras S. The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature. Am J Med 1980;69:187-94.
34. Magy N, Cribier B, Schmitt C, et al. Effects of corticosteroids on HCV infection. Int J Immunopharmacol 1999;21:253-61.
35. Cacoub P, Maisonobe T, Thibault V, et al. Systemic vasculitis in patients with hepatitis C. J Rheumatol 2001;28:109-18.
36. Di Bisceglie AM, Conjeevaram HS, Fried MW, et al. Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995;123:897-903.
37. Andant C, Lamoril J, Deybach JC, Jouet P, Soule JC. Amantadine for chronic hepatitis C: pilot study in 14 patients. Eur J Gastroenterol Hepatol 2000;12:1319-22.